SAB Biotherapeutics (SABSW:NASDAQ)

$0.0318 -0.00 (-0.62%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 77

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed SAB Biotherapeutics (SABSW:NASDAQ) News Sources

SAB Biotherapeutics Pitches SAB-142 as Redosable Human ATG for Type 1 Diabetes at Oppenheimer Conf

Yahoo Finance

external link

Business Talk – Entrepreneurs Gene Likhanya and Trudy Mkansi discuss how the SAB Foundation helped their businesses

BusinessTech

external link
SABSW stock
SABSW stock price
SABSW stock price today
SABSW stock prediction
SABSW earnings date
SABSW news
SABSW price
SABSW share
SABSW share price
SABSW shares
SABSW ceo
SABSW premarket
$SABSW
SABSW ticker
SABSW after hours
SABSW stock
SABSW stock price
SABSW stock price today
SABSW stock prediction
SABSW earnings date
SABSW news
SABSW price
SABSW share
SABSW share price
SABSW shares
SABSW ceo
SABSW premarket
$SABSW
SABSW ticker
SABSW after hours

SAB Biotherapeutics (SABSW:NASDAQ) FAQs

toggle

What is the current price of SAB Biotherapeutics (SABSW:NASDAQ)?

The current price of SAB Biotherapeutics (SABSW:NASDAQ) is $0.0318.


toggle

SAB Biotherapeutics (SABSW:NASDAQ) absolute price change since previous trading day?

The absolute price change of SAB Biotherapeutics (SABSW:NASDAQ) since the previous trading day is $-0.00.


toggle

SAB Biotherapeutics (SABSW:NASDAQ) percentage price change since previous trading day?

The percentage price change of SAB Biotherapeutics (SABSW:NASDAQ) since the previous trading day is -0.62%.


toggle

What is This Week's average sentiment score for SAB Biotherapeutics (SABSW:NASDAQ)?

This Week's average sentiment score for SAB Biotherapeutics (SABSW:NASDAQ) is 77 out of 100.


toggle

What is This Week's average sentiment for SAB Biotherapeutics (SABSW:NASDAQ)?

This Week's sentiment for SAB Biotherapeutics (SABSW:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.